138 related articles for article (PubMed ID: 34498339)
1. Knockdown of YKL-40 inhibits angiogenesis through regulation of VEGF/VEGFR2 and ERK1/2 signaling in endometrial cancer.
Chen HY; Zhou ZY; Luo YL; Luo Q; Fan JT
Cell Biol Int; 2021 Dec; 45(12):2557-2566. PubMed ID: 34498339
[TBL] [Abstract][Full Text] [Related]
2. ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway.
Zhang Q; Lu S; Li T; Yu L; Zhang Y; Zeng H; Qian X; Bi J; Lin Y
J Exp Clin Cancer Res; 2019 Apr; 38(1):173. PubMed ID: 31023337
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma.
Chen HX; Xu XX; Tan BZ; Zhang Z; Zhou XD
Cell Physiol Biochem; 2017; 41(3):933-946. PubMed ID: 28222438
[TBL] [Abstract][Full Text] [Related]
4. Integrin alpha x stimulates cancer angiogenesis through PI3K/Akt signaling-mediated VEGFR2/VEGF-A overexpression in blood vessel endothelial cells.
Wang J; Yang L; Liang F; Chen Y; Yang G
J Cell Biochem; 2019 Feb; 120(2):1807-1818. PubMed ID: 30873824
[TBL] [Abstract][Full Text] [Related]
5. Effects of a Small Interfering RNA Targeting YKL-40 Gene on the Proliferation and Invasion of Endometrial Cancer HEC-1A Cells.
Li LL; Fan JT; Li DH; Liu Y
Int J Gynecol Cancer; 2016 Sep; 26(7):1190-5. PubMed ID: 27465891
[TBL] [Abstract][Full Text] [Related]
6. 6'-Sialylgalactose inhibits vascular endothelial growth factor receptor 2-mediated angiogenesis.
Chung TW; Kim EY; Choi HJ; Han CW; Jang SB; Kim KJ; Jin L; Koh YJ; Ha KT
Exp Mol Med; 2019 Oct; 51(10):1-13. PubMed ID: 31604908
[TBL] [Abstract][Full Text] [Related]
7. DDA suppresses angiogenesis and tumor growth of colorectal cancer in vivo through decreasing VEGFR2 signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Oncotarget; 2016 Sep; 7(39):63124-63137. PubMed ID: 27517319
[TBL] [Abstract][Full Text] [Related]
8. Norcantharidin inhibits tumor angiogenesis via blocking VEGFR2/MEK/ERK signaling pathways.
Zhang L; Ji Q; Liu X; Chen X; Chen Z; Qiu Y; Sun J; Cai J; Zhu H; Li Q
Cancer Sci; 2013 May; 104(5):604-10. PubMed ID: 23363445
[TBL] [Abstract][Full Text] [Related]
9. Harmine suppresses bladder tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis.
Hai-Rong C; Xiang H; Xiao-Rong Z
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30910851
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor-related receptor γ uppresses hypoxia-induced angiogenesis by regulating VEGFA in endometrial cancer.
Wang XX; Hua T; Wang HB
Gynecol Endocrinol; 2023 Dec; 39(1):2264411. PubMed ID: 37859604
[TBL] [Abstract][Full Text] [Related]
11. Sulfated fucoidan FP08S2 inhibits lung cancer cell growth in vivo by disrupting angiogenesis via targeting VEGFR2/VEGF and blocking VEGFR2/Erk/VEGF signaling.
Chen H; Cong Q; Du Z; Liao W; Zhang L; Yao Y; Ding K
Cancer Lett; 2016 Nov; 382(1):44-52. PubMed ID: 27569654
[TBL] [Abstract][Full Text] [Related]
12. SUMOylation of vascular endothelial growth factor receptor 2 inhibits the proliferation, migration, and angiogenesis signaling pathway in non-small cell lung cancer.
Wang M; Jiang X
Anticancer Drugs; 2020 Jun; 31(5):492-499. PubMed ID: 31922962
[TBL] [Abstract][Full Text] [Related]
13. Dual blockade of VEGFR1 and VEGFR2 by a novel peptide abrogates VEGF-driven angiogenesis, tumor growth, and metastasis through PI3K/AKT and MAPK/ERK1/2 pathway.
Sadremomtaz A; Mansouri K; Alemzadeh G; Safa M; Rastaghi AE; Asghari SM
Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2688-2700. PubMed ID: 30251659
[TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
15. Cryptotanshinone inhibits VEGF-induced angiogenesis by targeting the VEGFR2 signaling pathway.
Xu X; Wu L; Zhou X; Zhou N; Zhuang Q; Yang J; Dai J; Wang H; Chen S; Mao W
Microvasc Res; 2017 May; 111():25-31. PubMed ID: 28040437
[TBL] [Abstract][Full Text] [Related]
16. L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways.
Gao F; Vasquez SX; Su F; Roberts S; Shah N; Grijalva V; Imaizumi S; Chattopadhyay A; Ganapathy E; Meriwether D; Johnston B; Anantharamaiah GM; Navab M; Fogelman AM; Reddy ST; Farias-Eisner R
Integr Biol (Camb); 2011 Apr; 3(4):479-89. PubMed ID: 21283904
[TBL] [Abstract][Full Text] [Related]
17. Slit2 Promotes Angiogenic Activity Via the Robo1-VEGFR2-ERK1/2 Pathway in Both In Vivo and In Vitro Studies.
Li S; Huang L; Sun Y; Bai Y; Yang F; Yu W; Li F; Zhang Q; Wang B; Geng JG; Li X
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5210-7. PubMed ID: 26244297
[TBL] [Abstract][Full Text] [Related]
18. miR-622 inhibits angiogenesis by suppressing the CXCR4-VEGFA axis in colorectal cancer.
Fang Y; Sun B; Wang J; Wang Y
Gene; 2019 May; 699():37-42. PubMed ID: 30851425
[TBL] [Abstract][Full Text] [Related]
19. Elevated YKL-40 serum levels may contribute to wet age-related macular degeneration via the ERK1/2 pathway.
Bin Y; Liu Y; Jiang S; Peng H
FEBS Open Bio; 2021 Nov; 11(11):2933-2942. PubMed ID: 34110111
[TBL] [Abstract][Full Text] [Related]
20. Myricetin Inhibits Breast Tumor Growth and Angiogenesis by Regulating VEGF/VEGFR2 and p38MAPK Signaling Pathways.
Zhou Z; Mao W; Li Y; Qi C; He Y
Anat Rec (Hoboken); 2019 Dec; 302(12):2186-2192. PubMed ID: 31266091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
